JP Stock MarketDetailed Quotes

4536 Santen Pharmaceutical

Watchlist
  • 1787.0
  • +27.0+1.53%
20min DelayNot Open Dec 4 15:30 JST
620.15BMarket Cap24.69P/E (Static)

Santen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
3.29%74.77B
8.22%301.97B
-0.15%79.13B
8.69%77.03B
15.83%73.42B
10.46%72.39B
4.80%279.04B
12.48%79.25B
5.71%70.87B
-0.61%63.38B
Cost of revenue
6.60%32.01B
9.12%123.26B
15.11%31.66B
8.79%32.15B
7.04%29.43B
5.70%30.02B
2.99%112.95B
1.98%27.5B
-0.97%29.55B
5.99%27.5B
Gross profit
0.95%42.77B
7.60%178.71B
-8.26%47.48B
8.61%44.88B
22.57%43.99B
14.11%42.37B
6.07%166.09B
19.00%51.75B
11.07%41.32B
-5.14%35.89B
Operating expense
-0.02%29.61B
-17.15%140.17B
0.90%45.09B
4.23%33.82B
-49.97%31.64B
2.85%29.62B
40.16%169.18B
31.52%44.69B
9.52%32.45B
124.41%63.24B
Selling and administrative expenses
1.49%21.38B
-4.91%91.53B
-12.92%26.78B
-7.03%21.58B
-3.32%22.11B
8.44%21.07B
13.91%96.26B
27.21%30.76B
12.26%23.21B
19.07%22.87B
-General and administrative expense
1.49%21.38B
-4.91%91.53B
-12.92%26.78B
-7.03%21.58B
-3.32%22.11B
8.44%21.07B
13.91%96.26B
27.21%30.76B
12.26%23.21B
19.07%22.87B
Research and development costs
-12.65%5.5B
-10.18%25.42B
8.96%7.21B
-22.49%5.75B
-14.08%6.16B
-11.24%6.3B
7.28%28.3B
-12.66%6.62B
14.71%7.42B
15.28%7.17B
Depreciation and amortization
4.47%2.43B
-0.49%9.47B
4.14%2.39B
15.74%2.38B
-9.23%2.37B
-8.81%2.33B
-2.22%9.52B
-7.50%2.29B
-16.57%2.06B
10.36%2.61B
-Depreciation
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Amortization
4.47%2.43B
-0.49%9.47B
4.14%2.39B
15.74%2.38B
-9.23%2.37B
-8.81%2.33B
-2.22%9.52B
-7.50%2.29B
-16.57%2.06B
10.36%2.61B
Other operating expenses
60.81%357M
-60.39%15.3B
10.82%8.9B
13,253.13%4.27B
-93.77%1.91B
393.33%222M
3,309.44%38.63B
1,580.13%8.03B
-77.62%32M
6,367.86%30.59B
Total other operating income
-79.21%63M
-56.07%1.55B
-93.94%182M
-40.84%155M
--908M
-8.73%303M
237.87%3.52B
313.93%3B
125.86%262M
----
Operating profit
3.18%13.16B
1,347.25%38.54B
-66.25%2.38B
24.63%11.06B
145.15%12.35B
52.99%12.75B
-108.61%-3.09B
-25.77%7.06B
17.14%8.87B
-383.49%-27.35B
Net non-operating interest income (expenses)
-66.55%295M
-215.61%-1.09B
-125.67%-1.42B
68.87%-217M
-19.29%-334M
-30.11%882M
-125.94%-346M
-173.71%-631M
-382.19%-697M
-245.68%-280M
Non-operating interest income
-33.14%702M
36.34%1.57B
62.89%259M
13.55%486M
18.75%152M
-24.19%1.05B
-54.66%1.15B
-88.05%159M
-20.74%428M
56.10%128M
Non-operating interest expense
142.26%407M
77.72%2.66B
113.04%1.68B
-37.51%703M
19.12%486M
36.59%168M
23.99%1.5B
66.32%790M
283.96%1.13B
150.31%408M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0
-220.70%-7.58B
-636.13%-4.65B
-103.45%-1.36B
-48.99%-809M
-46.64%-764M
-47.26%-2.36B
-50.96%-631M
-23.06%-667M
-56.94%-543M
Special income (charges)
Other non-operating income (expenses)
Income before tax
4.52%13.45B
615.16%29.87B
-163.60%-3.69B
26.30%9.48B
139.77%11.21B
41.81%12.87B
-116.28%-5.8B
-41.73%5.79B
3.15%7.51B
-405.53%-28.18B
Income tax
15.76%2.84B
-65.47%3.17B
-181.21%-3.81B
38.09%2.18B
335.69%2.34B
3.24%2.46B
8.98%9.18B
128.73%4.69B
-29.49%1.58B
-76.55%538M
Net income
1.87%10.61B
278.22%26.7B
-88.87%123M
23.17%7.31B
130.86%8.86B
55.52%10.41B
-155.11%-14.98B
-86.00%1.11B
17.63%5.93B
-514.46%-28.71B
Net income continuous operations
1.87%10.61B
278.22%26.7B
-88.87%123M
23.17%7.31B
130.87%8.86B
55.52%10.41B
-155.11%-14.98B
-86.00%1.11B
17.63%5.93B
-514.46%-28.71B
Noncontrolling interests
-1,200.00%-26M
271.43%60M
945.45%93M
41.30%-27M
60.00%-4M
-106.25%-2M
-20.69%-35M
-145.83%-11M
-46M
-10M
Net income attributable to the company
2.10%10.63B
278.23%26.64B
-97.40%29M
22.67%7.33B
130.89%8.87B
56.30%10.41B
-154.92%-14.95B
-85.82%1.12B
18.54%5.98B
-514.32%-28.7B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
2.10%10.63B
278.23%26.64B
-97.40%29M
22.67%7.33B
130.89%8.87B
56.30%10.41B
-154.92%-14.95B
-85.82%1.12B
18.54%5.98B
-514.32%-28.7B
Gross dividend payment
Basic earnings per share
5.94%29.59
288.06%72.59
-86.96%0.33
33.76%20.72
132.56%24.6
66.35%27.93
-156.71%-38.6
-87.14%2.53
22.94%15.49
-533.51%-75.56
Diluted earnings per share
5.92%29.5
287.49%72.37
-87.35%0.32
33.64%20.66
132.45%24.52
66.07%27.85
-156.79%-38.6
-87.12%2.53
22.80%15.46
-534.50%-75.56
Dividend per share
0
3.13%33
6.25%17
0
0.00%16
0
0.00%32
0.00%16
0
0.00%16
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue 3.29%74.77B8.22%301.97B-0.15%79.13B8.69%77.03B15.83%73.42B10.46%72.39B4.80%279.04B12.48%79.25B5.71%70.87B-0.61%63.38B
Cost of revenue 6.60%32.01B9.12%123.26B15.11%31.66B8.79%32.15B7.04%29.43B5.70%30.02B2.99%112.95B1.98%27.5B-0.97%29.55B5.99%27.5B
Gross profit 0.95%42.77B7.60%178.71B-8.26%47.48B8.61%44.88B22.57%43.99B14.11%42.37B6.07%166.09B19.00%51.75B11.07%41.32B-5.14%35.89B
Operating expense -0.02%29.61B-17.15%140.17B0.90%45.09B4.23%33.82B-49.97%31.64B2.85%29.62B40.16%169.18B31.52%44.69B9.52%32.45B124.41%63.24B
Selling and administrative expenses 1.49%21.38B-4.91%91.53B-12.92%26.78B-7.03%21.58B-3.32%22.11B8.44%21.07B13.91%96.26B27.21%30.76B12.26%23.21B19.07%22.87B
-General and administrative expense 1.49%21.38B-4.91%91.53B-12.92%26.78B-7.03%21.58B-3.32%22.11B8.44%21.07B13.91%96.26B27.21%30.76B12.26%23.21B19.07%22.87B
Research and development costs -12.65%5.5B-10.18%25.42B8.96%7.21B-22.49%5.75B-14.08%6.16B-11.24%6.3B7.28%28.3B-12.66%6.62B14.71%7.42B15.28%7.17B
Depreciation and amortization 4.47%2.43B-0.49%9.47B4.14%2.39B15.74%2.38B-9.23%2.37B-8.81%2.33B-2.22%9.52B-7.50%2.29B-16.57%2.06B10.36%2.61B
-Depreciation --0--0--0--0--0--0--0--0--0--0
-Amortization 4.47%2.43B-0.49%9.47B4.14%2.39B15.74%2.38B-9.23%2.37B-8.81%2.33B-2.22%9.52B-7.50%2.29B-16.57%2.06B10.36%2.61B
Other operating expenses 60.81%357M-60.39%15.3B10.82%8.9B13,253.13%4.27B-93.77%1.91B393.33%222M3,309.44%38.63B1,580.13%8.03B-77.62%32M6,367.86%30.59B
Total other operating income -79.21%63M-56.07%1.55B-93.94%182M-40.84%155M--908M-8.73%303M237.87%3.52B313.93%3B125.86%262M----
Operating profit 3.18%13.16B1,347.25%38.54B-66.25%2.38B24.63%11.06B145.15%12.35B52.99%12.75B-108.61%-3.09B-25.77%7.06B17.14%8.87B-383.49%-27.35B
Net non-operating interest income (expenses) -66.55%295M-215.61%-1.09B-125.67%-1.42B68.87%-217M-19.29%-334M-30.11%882M-125.94%-346M-173.71%-631M-382.19%-697M-245.68%-280M
Non-operating interest income -33.14%702M36.34%1.57B62.89%259M13.55%486M18.75%152M-24.19%1.05B-54.66%1.15B-88.05%159M-20.74%428M56.10%128M
Non-operating interest expense 142.26%407M77.72%2.66B113.04%1.68B-37.51%703M19.12%486M36.59%168M23.99%1.5B66.32%790M283.96%1.13B150.31%408M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 0-220.70%-7.58B-636.13%-4.65B-103.45%-1.36B-48.99%-809M-46.64%-764M-47.26%-2.36B-50.96%-631M-23.06%-667M-56.94%-543M
Special income (charges)
Other non-operating income (expenses)
Income before tax 4.52%13.45B615.16%29.87B-163.60%-3.69B26.30%9.48B139.77%11.21B41.81%12.87B-116.28%-5.8B-41.73%5.79B3.15%7.51B-405.53%-28.18B
Income tax 15.76%2.84B-65.47%3.17B-181.21%-3.81B38.09%2.18B335.69%2.34B3.24%2.46B8.98%9.18B128.73%4.69B-29.49%1.58B-76.55%538M
Net income 1.87%10.61B278.22%26.7B-88.87%123M23.17%7.31B130.86%8.86B55.52%10.41B-155.11%-14.98B-86.00%1.11B17.63%5.93B-514.46%-28.71B
Net income continuous operations 1.87%10.61B278.22%26.7B-88.87%123M23.17%7.31B130.87%8.86B55.52%10.41B-155.11%-14.98B-86.00%1.11B17.63%5.93B-514.46%-28.71B
Noncontrolling interests -1,200.00%-26M271.43%60M945.45%93M41.30%-27M60.00%-4M-106.25%-2M-20.69%-35M-145.83%-11M-46M-10M
Net income attributable to the company 2.10%10.63B278.23%26.64B-97.40%29M22.67%7.33B130.89%8.87B56.30%10.41B-154.92%-14.95B-85.82%1.12B18.54%5.98B-514.32%-28.7B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 2.10%10.63B278.23%26.64B-97.40%29M22.67%7.33B130.89%8.87B56.30%10.41B-154.92%-14.95B-85.82%1.12B18.54%5.98B-514.32%-28.7B
Gross dividend payment
Basic earnings per share 5.94%29.59288.06%72.59-86.96%0.3333.76%20.72132.56%24.666.35%27.93-156.71%-38.6-87.14%2.5322.94%15.49-533.51%-75.56
Diluted earnings per share 5.92%29.5287.49%72.37-87.35%0.3233.64%20.66132.45%24.5266.07%27.85-156.79%-38.6-87.12%2.5322.80%15.46-534.50%-75.56
Dividend per share 03.13%336.25%1700.00%1600.00%320.00%1600.00%16
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data